Orphit

Science de la vie

  • :
  • :Laboratoire INSERM-Univ Montpellier U1198, MMDN team

ORPHIT is developing innovative therapies for rare or incurable diseases.
CELLAXANE® is a vectorised paclitaxel for treating glioblastoma (brain tumors). CELLAXANE® is ready to move to the I/IIa clinical phase with leading European clinics and hospitals.
YMALZEN® is a small peptide, similar to a natural immunomodulatory hormone, repositioned in the treatment of Alzheimer's disease. YMALZEN® is ready to enter into phase IIa.

Orphit

  • Founded on

ORPHIT is developing innovative therapies for rare or incurable diseases.
CELLAXANE® is a vectorised paclitaxel for treating glioblastoma (brain tumors). CELLAXANE® is ready to move to the I/IIa clinical phase with leading European clinics and hospitals.
YMALZEN® is a small peptide, similar to a natural immunomodulatory hormone, repositioned in the treatment of Alzheimer's disease. YMALZEN® is ready to enter into phase IIa.